Location: New York, NY
CIK: 0001263508 · Show all filings
Period: Q3 2020 (← Previous) (Next →)
Filing Date: Nov 16, 2020
Total Value: $25.03B (99.7% shares, 0.3% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Seagen Inc. | 47,269,424 | $9.25B | 37.0% | $195.69 | — | COM | 81181C104 |
| ONC | BeiGene, Ltd. | 13,301,597 | $3.81B | 15.2% | $136.93 | — | SPONSORED ADR | 07725L102 |
| INCY | Incyte Corporation | 31,999,398 | $2.872B | 11.5% | $73.07 | +32.0% | COM | 45337C102 |
| ACAD | ACADIA Pharmaceuticals Inc. | 41,904,586 | $1.729B | 6.9% | $18.86 | +129.0% | COM | 004225108 |
| — | Alexion Pharmaceuticals, Inc. | 8,760,794 | $1.002B | 4.0% | $162.46 | — | COM | 015351109 |
| KOD | Kodiak Sciences Inc. | 12,352,175 | $731M | 2.9% | $17.88 | +180.7% | COM | 50015M109 |
| BMRN | BioMarin Pharmaceutical Inc. | 7,589,294 | $577M | 2.3% | $81.02 | +24.9% | COM | 09061G101 |
| ASND | Ascendis Pharma A/S | 3,540,270 | $546M | 2.2% | $48.88 | — | SPONSORED ADR | 04351P101 |
| — | Invitae Corporation | 11,850,962 | $514M | 2.1% | $20.14 | — | COM | 46185L103 |
| — | MyoKardia, Inc. | 3,009,344 | $410M | 1.6% | $72.13 | — | COM | 62857M105 |
| PRLD | Prelude Therapeutics Incorporated | 10,118,636 | $305M | 1.2% | $28.24 | 0.0% | COM | 74065P101 |
| ARGX | argenx SE | 1,019,557 | $268M | 1.1% | $59.75 | — | SPONSORED ADR | 04016X101 |
| — | Mirati Therapeutics, Inc. | 1,409,784 | $234M | 0.9% | $22.85 | — | COM | 60468T105 |
| — | IGM Biosciences, Inc. | 3,144,446 | $232M | 0.9% | $17.75 | — | COM | 449585108 |
| EXAS | Exact Sciences Corporation | 1,846,139 | $188M | 0.8% | $87.91 | -1.8% | COM | 30063P105 |
| MDGL | Madrigal Pharmaceuticals, Inc. | 1,499,213 | $178M | 0.7% | $104.81 | +3.6% | COM | 558868105 |
| — | Amarin Corporation plc | 32,018,867 | $135M | 0.5% | $8.93 | — | SPONSORED ADR | 023111206 |
| HRTX | Heron Therapeutics, Inc. | 5,994,704 | $88.84M | 0.4% | $17.78 | -12.2% | COM | 427746102 |
| — | Forma Therapeutics Holdings, Inc. | 1,771,509 | $88.29M | 0.4% | $46.49 | — | SHS | 34633R104 |
| CERS | Cerus Corporation | 13,713,195 | $85.84M | 0.3% | $4.64 | +43.0% | COM | 157085101 |
| — | Zymeworks Inc. | 1,708,472 | $79.58M | 0.3% | $14.76 | — | COM | 98985W102 |
| INSM | Insmed Incorporated | 2,272,712 | $73.05M | 0.3% | $22.18 | +29.6% | COM PAR $.01 | 457669307 |
| AXSM | Axsome Therapeutics, Inc. | 959,757 | $68.38M | 0.3% | $23.39 | +233.2% | COM | 05464T104 |
| NBIX | Neurocrine Biosciences, Inc. | 676,975 | $65.1M | 0.3% | $62.87 | +84.0% | COM | 64125C109 |
| KYMR | Kymera Therapeutics, Inc. | 1,959,211 | $63.3M | 0.3% | $30.53 | 0.0% | COM | 501575104 |
| NRIX | Nurix Therapeutics, Inc. | 1,788,921 | $62.45M | 0.2% | $25.20 | 0.0% | COM | 67080M103 |
| — | Allakos Inc. | 698,469 | $56.89M | 0.2% | $60.26 | — | COM | 01671P100 |
| ADCT | ADC Therapeutics SA | 1,687,500 | $55.67M | 0.2% | $38.22 | +13.2% | SHS | H0036K147 |
| RYTM | Rhythm Pharmaceuticals, Inc. | 2,471,155 | $53.55M | 0.2% | $26.63 | -13.9% | COM | 76243J105 |
| — | Horizon Therapeutics Public Ltd Co | 666,500 | $51.77M | 0.2% | $63.26 | — | SHS | G46188101 |
| — | Global Blood Therapeutics, Inc. | 920,375 | $50.75M | 0.2% | $54.93 | — | COM | 37890U108 |
| ADAPY | Adaptimmune Therapeutics plc | 6,330,354 | $50.52M | 0.2% | $5.98 | — | SPONSORED ADR | 00653A107 |
| — | Atreca, Inc. | 3,532,760 | $49.35M | 0.2% | $18.84 | — | CL A COM | 04965G109 |
| — | ChemoCentryx, Inc. | 899,821 | $49.31M | 0.2% | $35.60 | — | COM | 16383L106 |
| — | Neoleukin Therapeutics, Inc. | 3,821,740 | $45.86M | 0.2% | $3.87 | — | COM | 64049K104 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 12,695,818 | $43.61M | 0.2% | $6.35 | -32.5% | COM | 09058V103 |
| — | Kiniksa Pharmaceuticals, Ltd. | 2,799,577 | $42.89M | 0.2% | $17.35 | — | COM CL A | G5269C101 |
| — | Neurocrine Biosciences, Inc. | 30,770,000 | $42.34M | 0.2% | $1.24 | — | NOTE 2.25% 5/15/2024 | 64125CAD1 |
| KRYS | Krystal Biotech, Inc. | 775,192 | $33.37M | 0.1% | $22.57 | +92.4% | COM | 501147102 |
| PACB | Pacific Biosciences of California, Inc. | 3,250,000 | $32.08M | 0.1% | $5.76 | 0.0% | COM | 69404D108 |
| PTGX | Protagonist Therapeutics, Inc. | 1,596,198 | $31.21M | 0.1% | $9.97 | +88.2% | COM | 74366E102 |
| — | Aeglea BioTherapeutics, Inc. | 4,379,592 | $31.05M | 0.1% | $7.84 | — | COM | 00773J103 |
| ALT | Altimmune, Inc. | 2,206,955 | $29.13M | 0.1% | $6.15 | +225.2% | COM | 02155H200 |
| APLS | Apellis Pharmaceuticals, Inc. | 896,551 | $27.05M | 0.1% | $28.57 | +4.6% | COM | 03753U106 |
| — | Assembly Biosciences, Inc. | 1,541,418 | $25.34M | 0.1% | $17.50 | — | COM | 045396108 |
| — | DBV Technologies S.A. | 14,614,264 | $25.28M | 0.1% | $19.06 | — | SPONSORED ADR | 23306J101 |
| — | Merus N.V. | 2,037,469 | $24.45M | 0.1% | $10.77 | — | COM | N5749R100 |
| AUPH | Aurinia Pharmaceuticals Inc. | 1,618,029 | $23.83M | 0.1% | $9.21 | +57.3% | COM | 05156V102 |
| — | Cymabay Therapeutics, Inc. | 3,252,542 | $23.55M | 0.1% | $5.48 | — | COM | 23257D103 |
| ALKS | Alkermes plc | 1,359,001 | $22.52M | 0.1% | $23.69 | -23.3% | SHS | G01767105 |
| FLGT | Fulgent Genetics, Inc. | 546,189 | $21.87M | 0.1% | $11.30 | +177.1% | COM | 359664109 |
| ADPT | Adaptive Biotechnologies Corporation | 440,539 | $21.42M | 0.1% | $44.30 | -5.1% | COM | 00650F109 |
| NVAX | Novavax, Inc. | 187,376 | $20.3M | 0.1% | $38.25 | +218.5% | COM | 670002401 |
| — | Immunomedics, Inc. | 237,694 | $20.21M | 0.1% | $14.81 | — | COM | 452907108 |
| — | Albireo Pharma, Inc. | 549,047 | $18.32M | 0.1% | $24.96 | — | COM | 01345P106 |
| — | Frequency Therapeutics, Inc. | 949,555 | $18.24M | 0.1% | $17.53 | — | COM | 35803L108 |
| — | Invitae Corporation | 10,300,000 | $16.91M | 0.1% | $1.64 | — | NOTE 2.0% 9/1/2024 | 46185LAB9 |
| — | Athira Pharma, Inc. | 882,352 | $16.29M | 0.1% | $18.46 | — | COM | 04746L104 |
| XNCR | Xencor, Inc. | 410,142 | $15.91M | 0.1% | $11.07 | +213.9% | COM | 98401F105 |
| — | BioMarin Pharmaceutical Inc. | 15,000,000 | $15.65M | 0.1% | $1.01 | — | NOTE 0.599% 8/1/2024 | 09061GAH4 |
| — | bluebird bio, Inc. | 252,000 | $13.6M | 0.1% | $58.05 | — | COM | 09609G100 |
| HRMY | Harmony Biosciences Holdings, Inc. | 400,000 | $13.56M | 0.1% | $36.46 | 0.0% | COM | 413197104 |
| — | GW Pharmaceuticals plc | 138,745 | $13.51M | 0.1% | $132.99 | — | ADS | 36197T103 |
| MIRM | Mirum Pharmaceuticals, Inc. | 553,009 | $10.66M | 0.0% | $14.04 | +52.8% | COM | 604749101 |
| IMTX | Immatics N.V. | 1,001,414 | $10.63M | 0.0% | $10.53 | 0.0% | SHS | N44445109 |
| VXRT | Vaxart, Inc. | 1,566,121 | $10.41M | 0.0% | $2.87 | +210.0% | COM | 92243A200 |
| — | Idera Pharmaceuticals, Inc. | 4,608,786 | $9.863M | 0.0% | $1.32 | — | COM PAR | 45168K405 |
| UROV | Urovant Sciences Ltd. | 978,505 | $9.139M | 0.0% | $15.51 | — | SHS | G9381B108 |
| SGMO | Sangamo Therapeutics, Inc. | 949,823 | $8.976M | 0.0% | $11.28 | -4.1% | COM | 800677106 |
| XENE | Xenon Pharmaceuticals Inc. | 760,308 | $8.417M | 0.0% | $12.73 | -7.5% | COM | 98420N105 |
| — | IVERIC bio, Inc. | 1,406,037 | $7.93M | 0.0% | $3.89 | — | COM | 46583P102 |
| ANAB | AnaptysBio, Inc. | 487,243 | $7.187M | 0.0% | $26.06 | -30.8% | COM | 032724106 |
| QURE | uniQure N.V. | 194,383 | $7.159M | 0.0% | $18.33 | +123.5% | SHS | N90064101 |
| CABA | Cabaletta Bio, Inc. | 636,363 | $6.898M | 0.0% | $11.85 | -3.0% | COM | 12674W109 |
| — | HOOKIPA Pharma Inc. | 700,481 | $6.634M | 0.0% | $6.73 | — | COM | 43906K100 |
| — | Syros Pharmaceuticals, Inc. | 690,167 | $6.101M | 0.0% | $13.72 | — | COM | 87184Q107 |
| — | Karuna Therapeutics, Inc. | 77,776 | $6.014M | 0.0% | $91.25 | — | COM | 48576A100 |
| — | Burning Rock Biotech Limited | 237,300 | $5.951M | 0.0% | $27.01 | — | SPONSORED ADS | 12233L107 |
| AUTL | Autolus Therapeutics plc | 461,324 | $5.37M | 0.0% | $19.50 | — | SPONSORED ADS | 05280R100 |
| — | Reata Pharmaceuticals, Inc. | 53,183 | $5.181M | 0.0% | $188.33 | — | CL A | 75615P103 |
| REPL | Replimune Group, Inc. | 206,586 | $4.756M | 0.0% | $22.66 | +0.6% | COM | 76029N106 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 302,320 | $4.737M | 0.0% | $22.63 | -32.4% | COM | 22663K107 |
| IFRX | Inflarx N.V. | 1,007,559 | $4.292M | 0.0% | $2.91 | +58.4% | COM | N44821101 |
| — | Iteos Therapeutics, Inc. | 167,562 | $4.134M | 0.0% | $24.67 | — | COM | 46565G104 |
| — | Akero Therapeutics, Inc. | 131,788 | $4.058M | 0.0% | $30.79 | — | COM | 00973Y108 |
| LEGN | Legend Biotech Corporation | 128,200 | $3.958M | 0.0% | $42.56 | — | SPONSORED ADS | 52490G102 |
| DNLI | Denali Therapeutics Inc. | 99,400 | $3.562M | 0.0% | $20.86 | +44.4% | COM | 24823R105 |
| — | Passage Bio, Inc. | 261,066 | $3.423M | 0.0% | $15.75 | — | COM | 702712100 |
| OVID | Ovid Therapeutics Inc. | 590,761 | $3.391M | 0.0% | $4.98 | +34.5% | COM | 690469101 |
| TARA | Protara Therapeutics, Inc. | 199,671 | $3.36M | 0.0% | $30.96 | -25.1% | COM STK | 74365U107 |
| — | Chiasma, Inc. | 742,133 | $3.191M | 0.0% | $5.38 | — | COM | 16706W102 |
| — | Inozyme Pharma, Inc. | 118,500 | $3.115M | 0.0% | $26.29 | — | COM | 45790W108 |
| — | Acceleron Pharma Inc. | 25,640 | $2.885M | 0.0% | $89.85 | — | COM | 00434H108 |
| ALEC | Alector, Inc. | 265,600 | $2.798M | 0.0% | $25.49 | -36.5% | COM | 014442107 |
| — | Kezar Life Sciences, Inc. | 574,958 | $2.783M | 0.0% | $5.18 | — | COM | 49372L100 |
| — | Constellation Pharmaceuticals, Inc. | 133,333 | $2.701M | 0.0% | $6.73 | — | COM | 210373106 |
| — | Gamida Cell Ltd. | 633,324 | $2.628M | 0.0% | $4.57 | — | SHS | M47364100 |
| — | TCR2 Therapeutics Inc. | 122,532 | $2.49M | 0.0% | $20.32 | — | COM | 87808K106 |
| NTLA | Intellia Therapeutics, Inc. | 122,238 | $2.43M | 0.0% | $26.35 | -20.9% | COM | 45826J105 |
| VKTX | Viking Therapeutics, Inc. | 404,200 | $2.352M | 0.0% | $11.90 | -42.1% | COM | 92686J106 |
| — | Dicerna Pharmaceuticals, Inc. | 113,135 | $2.035M | 0.0% | $20.57 | — | COM | 253031108 |
| RCUS | Arcus Biosciences, Inc. | 115,425 | $1.978M | 0.0% | $15.69 | +42.4% | COM | 03969F109 |
| — | NGM Biopharmaceuticals, Inc. | 118,100 | $1.879M | 0.0% | $14.64 | — | COM | 62921N105 |
| GLPG | Galapagos NV | 12,412 | $1.761M | 0.0% | $51.50 | — | SPONSORED ADR | 36315X101 |
| — | Bellicum Pharmaceuticals, Inc. | 249,123 | $1.637M | 0.0% | $4.71 | — | COM | 079481404 |
| — | Molecular Templates, Inc. | 148,817 | $1.625M | 0.0% | $7.45 | — | COM | 608550109 |
| — | Oyster Point Pharma, Inc. | 68,228 | $1.44M | 0.0% | $28.88 | — | COM | 69242L106 |
| — | Orchard Therapeutics plc | 343,202 | $1.411M | 0.0% | $14.53 | — | ADS | 68570P101 |
| CPRX | Catalyst Pharmaceuticals, Inc. | 474,400 | $1.409M | 0.0% | $2.70 | +44.7% | COM | 14888U101 |
| — | Genetron Holdings Limited | 100,000 | $1.194M | 0.0% | $11.94 | — | ADS | 37186H100 |
| — | Leap Therapeutics, Inc. | 559,705 | $1.108M | 0.0% | $1.17 | — | COM | 52187K101 |
| — | Evofem Biosciences, Inc. | 433,048 | $1.022M | 0.0% | $4.22 | — | COM | 30048L104 |
| — | Applied Therapeutics, Inc. | 38,034 | $790K | 0.0% | $32.68 | — | COM | 03828A101 |
| — | Galmed Pharmaceuticals Ltd. | 205,375 | $725K | 0.0% | $11.90 | — | SHS | M47238106 |
| INFIQ | Infinity Pharmaceuticals, Inc. | 580,400 | $679K | 0.0% | $1.54 | -33.1% | COM | 45665G303 |
| — | Adamas Pharmaceuticals, Inc. | 163,830 | $675K | 0.0% | $14.46 | — | COM | 00548A106 |
| — | Affimed N.V. | 189,800 | $643K | 0.0% | $6.30 | — | COM | N01045108 |
| — | Aravive, Inc. | 75,854 | $357K | 0.0% | $5.03 | — | COM | 03890D108 |
| GNFTY | Genfit SA | 28,396 | $150K | 0.0% | $14.24 | — | ADS | 372279109 |
| — | Sunesis Pharmaceuticals, Inc. | 53,066 | $66,000 | 0.0% | $4.37 | — | COM PAR | 867328700 |